Go Deep
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 15,711 | 13.5 | 5.60 | 2.02 | 5,881.83 |
| Oct 2026 | 15,711 | 13.5 | 5.60 | 2.02 | 5,881.22 |
| Oct 2026 | 15,711 | 13.5 | 5.60 | 2.02 | 5,881.22 |
| Oct 2026 | 15,989 | 13.0 | 5.38 | 2.02 | 5,656.17 |
| Oct 2026 | 16,146 | 13.1 | 5.45 | 2.02 | 5,745.55 |
| Oct 2026 | 16,146 | 13.0 | 5.45 | 2.02 | 5,745.55 |
| Oct 2026 | 16,133 | 13.2 | 5.46 | 2.02 | 5,763.19 |
| Oct 2026 | 16,147 | 13.1 | 5.45 | 2.02 | 5,751.60 |
| Oct 2026 | 15,952 | 13.0 | 5.41 | 2.02 | 5,720.24 |
| Oct 2026 | 16,134 | 12.7 | 5.27 | 2.02 | 5,512.74 |
| Oct 2026 | 17,251 | 12.5 | 5.19 | 2.02 | 5,396.89 |
| Oct 2026 | 16,941 | 13.1 | 5.43 | 2.02 | 5,628.49 |
| Oct 2026 | 16,789 | 12.8 | 5.54 | 2.02 | 5,751.79 |
| Oct 2026 | 16,885 | 13.2 | 5.47 | 2.02 | 5,659.22 |
| Oct 2026 | 16,995 | 13.0 | 5.38 | 2.02 | 5,578.05 |
| Oct 2026 | 16,656 | 13.6 | 5.64 | 2.02 | 5,848.27 |
| Oct 2026 | 16,723 | 13.5 | 5.59 | 2.02 | 5,780.86 |
| Oct 2026 | 16,499 | 13.9 | 5.77 | 2.02 | 5,946.62 |
| Oct 2026 | 16,680 | 13.5 | 5.63 | 2.02 | 5,827.21 |
Bristol-Myers Squibb Company Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 12,973,000,000.0 | 11,489,000,000.0 | 12,503,000,000.0 | 12,222,000,000.0 |
| Net Profit | 3,317,000,000.0 | 2,677,000,000.0 | 1,087,000,000.0 | 2,201,000,000.0 |
| EPS | 1.6 | 1.3 | 0.5 | 1.1 |
Bristol-Myers Squibb Company Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 48,195,000,000.0 | 48,300,000,000.0 | 45,006,000,000.0 | 46,159,000,000.0 | — |
| Net Profit | 7,054,000,000.0 | -8,948,000,000.0 | 8,025,000,000.0 | 6,327,000,000.0 | — |
| EPS | 3.5 | -4.4 | 3.9 | 3.0 | — |
Bristol-Myers Squibb Company Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 90,038,000,000.0 | 92,603,000,000.0 | 95,159,000,000.0 | 96,820,000,000.0 | — |
| Total Liabilities | 71,532,000,000.0 | 76,215,000,000.0 | 65,674,000,000.0 | 65,702,000,000.0 | — |
| Total Equity | 18,473,000,000.0 | 16,335,000,000.0 | 29,430,000,000.0 | 31,061,000,000.0 | — |
Owes vs Owns
Bristol-Myers Squibb Company owed $0.75 for every $1 it owned in Jun 2026, up from $0.68 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.75× | 0.79× | 0.82× | 0.69× | 0.68× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Bristol-Myers Squibb Company Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 11.9%Receivables 16.1%Inventory 3.0%Fixed assets (tangible) 10.1%Intangible assets 45.7%Long-term investments 2.8%Other assets 10.5%
How it's funded — Dec 2025
Short-term debt 2.5%Long-term debt 47.6%Payables 4.0%Other liabilities 25.4%Shareholders' equity 20.6%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 10,673.0 | 10,859.0 | 12,280.0 | 9,253.0 |
| Receivables | 14,525.0 | 14,424.0 | 15,264.0 | 13,937.0 |
| Inventory | 2,690.0 | 2,557.0 | 2,662.0 | 2,339.0 |
| Fixed assets (tangible) | 9,125.0 | 8,360.0 | 8,036.0 | 7,475.0 |
| Intangible assets | 41,107.0 | 45,362.0 | 48,654.0 | 57,504.0 |
| Long-term investments | 2,507.0 | 2,508.0 | 2,499.0 | 2,187.0 |
| Other assets | 9,411.0 | 8,533.0 | 5,764.0 | 4,125.0 |
| Liabilities & equity | ||||
| Short-term debt | 2,261.0 | 2,046.0 | 3,119.0 | 4,264.0 |
| Long-term debt | 42,850.0 | 47,603.0 | 36,653.0 | 35,056.0 |
| Payables | 3,575.0 | 3,602.0 | 3,259.0 | 3,040.0 |
| Other liabilities | 22,846.0 | 22,964.0 | 22,643.0 | 23,342.0 |
| Shareholders' equity | 18,506.0 | 16,388.0 | 29,485.0 | 31,118.0 |
| Net tangible assets | -22,634.0 | -29,027.0 | -19,224.0 | -26,443.0 |
Bristol-Myers Squibb Company Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 14,156,000,000.0 | 15,190,000,000.0 | 13,860,000,000.0 | 13,066,000,000.0 | — |
| Investing Activities | -4,132,000,000.0 | -21,352,000,000.0 | -2,295,000,000.0 | -1,062,000,000.0 | — |
| Financing Activities | -10,348,000,000.0 | 5,127,000,000.0 | -9,416,000,000.0 | -16,962,000,000.0 | — |